The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, Texas, Indiana, and New Jersey.

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Novartis, a global medicines company, has announced a planned USD 23 billion investment over 5 years in US-based ...

The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

Novartis (NVS, Financials) is investing $23 billion over the next five years to expand its manufacturing and research ...

Novartis plans to invest $23 billion over the next five years to expand its manufacturing and research in the U.S. The investment will cover more than 10 facilities, including seven new sites, and ...

Investment is expected to bring approximately 1,000 new jobs at Novartis and 4,000 additional roles across the United States.

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it grapples with renewed threats of drug import duties from the Trump ...